These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 20594986

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Evaluation of nystatin in prevention and elimination of oropharyngeal Candida in immunosuppressed patients.
    Barrett AP.
    Oral Surg Oral Med Oral Pathol; 1984 Aug; 58(2):148-51. PubMed ID: 6592508
    [Abstract] [Full Text] [Related]

  • 63. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck.
    Epstein JB, Freilich MM, Le ND.
    Oral Surg Oral Med Oral Pathol; 1993 Aug; 76(2):169-74. PubMed ID: 8361726
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Favorable response of chronic candidas to amphotericin B.
    Hoyer S, Moe PJ.
    Acta Paediatr Scand; 1967 Aug; ():Suppl 177:108. PubMed ID: 5586079
    [No Abstract] [Full Text] [Related]

  • 66. Genital colonisation and infection with candida in heterosexual and homosexual males.
    David LM, Walzman M, Rajamanoharan S.
    Genitourin Med; 1997 Oct; 73(5):394-6. PubMed ID: 9534752
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Opportunistic candidiasis: an epidemic of the 1980s.
    Fisher-Hoch SP, Hutwagner L.
    Clin Infect Dis; 1995 Oct; 21(4):897-904. PubMed ID: 8645837
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. [The Fungizone preparation (amphotericin B) in the treatment of oral candidiasis].
    Knychalska-Karwan Z, Gawrzewska B, Chomyszyn-Gajewska M.
    Czas Stomatol; 1988 Apr; 41(4):253-5. PubMed ID: 3271667
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Oral and oropharyngeal prevalence of Enterobacteriaceae in humans: a review.
    Sedgley CM, Samaranayake LP.
    J Oral Pathol Med; 1994 Mar; 23(3):104-13. PubMed ID: 8021843
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. [Pimafucin in the treatment of various oral mucosa diseases complicated by candidiasis].
    Syryńska M, Stelmaska-Dworak E.
    Czas Stomatol; 1982 Oct; 35(10):725-9. PubMed ID: 6985209
    [No Abstract] [Full Text] [Related]

  • 80. Candidiasis in patients treated with interleukin-17 inhibitors.
    Báez-Gutierrez N, Rodríguez-Ramallo H.
    Indian J Pharmacol; 2021 Oct; 53(3):244-245. PubMed ID: 34169912
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.